GeneFab Transaction - Schedule of Disposal Groups, Including Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating expenses:
Net income from discontinued operations	$ 0	$ 21,692	$ 0	$ 12,376
GeneFab | Discontinued Operations, Disposed of by Sale | Non-Oncology Business
Operating expenses:
Research and development		1,641		9,975
General and administrative		(1,478)		(496)
Total operating expenses		163		9,479
Loss from discontinued operations		(163)		(9,479)
Other expense		(6)		(6)
Gain on disposal of business		21,861		21,861	$ 21,900
Net income from discontinued operations		$ 21,692		12,376
Cash flows from operating activities
Depreciation				185
Stock-based compensation				(2,022)
Investing activities:
Purchases of property and equipment				$ (4,079)